Transforming Diabetes
Research into
Real-World Solutions
We specialize in groundbreaking diabetes research, turning preclinical insights into proof-of-concept studies for both healthy volunteers and patients with diabetes. Our mission is to tackle one of the most pressing healthcare challenges of our time.
Diabetes: A Global
Health Concern
Diabetes represents a major global health issue, affecting approximately 422 million people and causing 1.6 million deaths annually (WHO). The International Diabetes Federation (IDF) predicts this number will soar to nearly 600 million by 2030. While Type 1 diabetes and late-onset autoimmune diabetes are rising, Type 2 diabetes is spreading pandemically, compounded by comorbidities like obesity, insulin resistance, lipid disorders, and hypertension. These complexities underscore the urgent need for advanced research and innovative treatments.
Bridging Research to Clinical Practice
From Bench to Bedside
We excel in converting preclinical research into clinical applications, bridging the gap from lab to patient care. Our proprietary volunteer and patient database, combined with a robust network of medical specialists, ensures efficient recruitment for studies. Our state-of-the-art Early Phase Clinical Trial Units, adhering to FDA and EMA regulations and GCP standards, guarantee the highest quality in clinical trials.
Comprehensive Study Support
Our multidisciplinary team of scientists, project managers, and medical writers guides every aspect of the research journey, from initial study design to publication. Our extensive track record of publications in top international peer-reviewed journals underscores our leadership in advancing diabetes research.
Advanced Metabolic Investigations
We offer a comprehensive suite of metabolic investigations using cutting-edge methods to assess drug effects. This includes:
- Glucose Tolerance Testing (OGTT / IVGTT)
- Standardized Test Meals
- Insulin Resistance Measurements
- Quicki (Insulin Sensitivity Check Index)
- Arginine and Glucagon Tests
- Continuous Glucose Monitoring (CGM)
- Glucose Clamping (M-value)
- HOMA-IR (Insulin Resistance Index)
- Alpha and Beta Cell Function Assessments
Additionally, in collaboration with leading scientific partners, we offer advanced imaging services and extensive biomarker measurements, facilitating comprehensive evaluations in drug research.
Our Commitment to Innovation
We continuously enhance our diagnostic capabilities with cutting-edge technologies to deliver precise assessments of new drugs and therapeutic interventions. Join us in our mission to revolutionize diabetes care and improve patient outcomes worldwide.